European Diabetes Nursing

Cover image for Vol. 11 Issue 3

Online ISSN: 1551-7861


Author Guidelines


NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement

For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools.



Author Guidelines


ADDRESS FOR ENQUIRIES AND SUBMISSIONS

Articles for European Diabetes Nursing should be submitted as a Word document to htupsy@wiley.com or posted on a disk to: Helen Tupsy, European Diabetes Nursing, John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester PO19 8SQ

 

Authors must also supply permission letters – it is the authors responsibility to obtain written permission to reproduce (in all media, including electronic) material that has appeared in another publication

 

Submission of a manuscript will be assumed to contain original unpublished work that is not being submitted for publication elsewhere at the same time. A conflict of interest statement should be included for each author, where appropriate.

 

TYPES OF ARTICLE PUBLISHED

Manuscripts should clearly state to which category of article they belong. The following are the main categories of articles published:

 

Original: Articles should represent the author(s) own research work and conform to the accepted scientific structure: Abstract (Background, Aims, Participants, Methods, Results, Conclusions); Introduction; Materials (or Patients) and Methods; Results; Discussion; Acknowledgements; References.

 

Review: Articles should constitute an original summation of existing knowledge. They need not follow a set format.

 

Case Report: Articles should follow the usual structure of: Abstract, Introduction, Case

History, Discussion/Comments, Acknowledgements, References.

 

Practice Point: Articles are intended to describe the specialist experience of different health professionals involved in diabetes management. They need not follow a set format.

 

Short Report: Original papers of not more than 1,000 words. Flexibility of format is permitted.

 

Personal Comment: Articles should express a personal theory or point of view, not necessarily involving original research or an objective overview of a subject.

 

Other: Editorials, Letters, Conference Reports, Book Reviews, Political Comments.

 

MANUSCRIPT STYLE

The language of the journal is English. All submissions including book reviews must have a title.

 

Please take into account the following points:

 

Abstract: of up to 250 words for all articles [except book reviews and Editorials]. The abstract should be a concise summary of the whole paper, not just the conclusions, and must be understandable without reference to the rest of the paper. It should contain no citation of other published work.

 

Key words: Authors are requested to cite key words (maximum number eight) at the beginning of each article.

 

Length: Articles should be between 1,000 and 2,500 words in length, including references and as many figures/tables and illustrations as necessary. Abstracts to articles should not exceed 250 words. Editorials should be approximately 750 words.

 

Title page: Manuscripts should include the title of the paper and the author(s) name(s), initials, qualifications and posts (current and at the time of writing the article, if different). A correspondence address should be given.

 

Scientific measurements: These should be given in standard international (SI) units, except where convention dictates otherwise.

 

Abbreviated titles: Authors are requested to give alternative abbreviated titles for their articles, where these comprise more than 10 words, for use as running heads on follow-on pages.

 

Headings: The use of headings, even where these are not mandatory as in Original Articles, is encouraged to help the reader follow the line of reasoning.

 

References: References should be numbered in the order in which they appear in the text and be indicated in the text by means of an arabic number in superscript. A full list of references in numerical order should be given at the end of the article. If citing an article, the reference should include, in the following order: Authors’ surnames and initials; title of article; title of journal abbreviated according to the style of Index Medicus; year of publication; volume; first and last pages of article. For example:

 

1.  Prentice AM, Black AE, Coward WA, et al. High levels of energy expenditure in obese women. BMJ 1986; 292: 983–87

 

If citing a book, the correct information and order is: Authors’ surnames and initials; title of book; edition; city of publication; publisher; year of publication; page(s). For example:

 

1. Mandell GL, Douglas RG-Jr, Bennet JE. Principles and Practice of Infectious Diseases, 3rd edn. London: Churchill-Livingstone 1990, 1673–87

 

or, for a chapter in a book:

 

1. Andrews FM. Comparative studies of life quality. In: Szalai A, Andrews FM, eds. Quality of Life; Comparative Studies. London: Sage 1980, 273–85

 

For online reference:

 

1.The Oncology Website. www.mit.com/oncology/[24 April 2004]

 

Authors must verify references before submission and they should be up-to-date.

 

Tables: Tables should be clearly identified, numbered in the order in which they are cited in the text and accompanied by explanatory headings/captions.

 

Figures: Figures should be clearly identified and numbered in the order in which they are cited in the text. They should be able to withstand enlargement or reduction as required.

Legends for figures should be clearly identified and be as short as possible. Authors must ensure that patients (or healthy volunteers) shown in photographs are not recognisable; otherwise, written permission is necessary from that person or his/her parent/ guardian/next of kin. Where figures have been published elsewhere, the previous publisher’s and author’s written consent to re-publication in European Diabetes Nursing must accompany the manuscript.

 

OTHER POINTS

Proofs: Proofs of articles accepted for publication in European Diabetes Nursing will be sent to the (designated) author before publication. Non-reply within the given period will be taken to indicate that no corrections are necessary. Proofs of Letters to the Editor are not normally sent.

 

Copyright: All articles submitted to European Diabetes Nursing are deemed to have been offered exclusively to the journal, unless otherwise stated. Articles must not have been, or be about to be, published elsewhere, either wholly or in part. Worldwide copyright of papers published in European Diabetes Nursing will be vested in The Federation of European Nurses in Diabetes (FEND) and the Publishers.

 

Authorship of articles: All authors credited should have made a significant contribution to the article, for example: conception and design; analysis and interpretation of data; drafting or critical revision; final approval of the version to be published.

 

Publication policies: Commissioned and submitted work must comply with these editorial policies, which are also based on the Committee on Publication Ethics (COPE) guidelines on good publication and comply with their Code of Conduct.(1)

 

The Editor aims to ensure that all articles published in European Diabetes Nursing (hereinafter called ‘the Journal’) meet internationally accepted ethical standards.

 

Acceptance: Commissioned and submitted articles will be accepted for publication following peer review and acceptance by the editor. The Journal has the right to reject any commissioned article or submitted article.

 

Peer review: Commissioned and submitted articles will be subject to peer review by board members and other specialists identified by the editor.  Authors will be asked to address peer comments before articles are accepted for publication.

 

Editing and illustration: Accepted articles will be subedited for style, ease of reading and length. Illustrations may be suggested in addition to any supplied by the authors. Authors will be asked to approve proofs prior to publication.

 

Copyright: All authors are required to sign a copyright transfer agreement prior to publication .

 

Payments: Payments for commissioned articles will be made in a timely fashion on publication. Where publication is delayed beyond six months an advance payment may be made.

 

Payments for articles will not be made where articles are rejected on the basis of quality and accuracy.  Payments may be made where commissioned articles are not published for other reasons eg an article going out of date while in production. However, every effort will be made to publish commissioned work.

 

Informed consent: Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. When informed consent has been obtained it should be indicated in the submitted article.

 

Research ethics: Authors are asked to confirm that their study has been approved by relevant bodies (eg institutional review boards, research ethics committees) and that appropriate consent was obtained for studies involving human participants.

 

Role of professional medical writers in peer-reviewed publications: Authors must follow the guidelines by the European Medical Writers Association on the role of medical writers.2 The guidelines emphasise the importance of respecting widely recognised authorship criteria, and in particular of ensuring that all people listed as named authors have full control of the content of papers. The role of professional medical writers must be transparent.

 

Any professional medical writer must be named among the list of contributors to any article for the Journal (not only original research papers), and it will be specified in the acknowledgments and statement of competing interests for the article who paid the writer.

 

Disclosure and competing interests statements: Authors are required to disclose financial interests in any company or institution that might benefit from their publication. Financial interests have the greatest potential to influence the objectivity, integrity or perceived value of a publication. They may include any or all, but are not limited to, the following:

 

        Personal financial interests: Stocks or shares in companies that may gain or lose financially through publication; consultant/advisory fees or fees for speaking at meetings or other forms of remuneration from organisations that may gain or lose financially. Any payments from companies to the author for writing the article.

        Funding: Research support from organisations that might gain or lose financially through publication of the paper;

        Employment: Recent, present or anticipated employment of authors or family members by any organisation that may gain or lose financially through publication of the paper.

 

Authors will be required to declare any competing interests prior to publication and these interests will be included within the published article under “Declarations of interest”.

 

For papers where there are no competing interests, all authors must include the statement the authors have no competing interests.’

 

Peer reviewers are also asked to declare any competing interests (these are not published).

 

Corrections: The Journal will publish corrections when errors could affect the interpretation of the content of the article, whatever the cause of the error (i.e. arising from author or publisher errors).  Where errors are identified post print but prior to online posting the error will be corrected on the online version.

 

Handling editors and editorial board members competing interests: Editors or Editorial Board members are never involved in editorial decisions about their own work. Journal editors, Editorial Board members and other editorial staff (including peer reviewers) withdraw from discussions about submissions where any circumstances might prevent him/her offering unbiased editorial decisions. Editors and members of the Editorial Board disclose their competing interests on an annual basis.

 

REFERENCES

  1. Graf C, Wagner E, Bowman A, Fiack S, Scott-Lichter D, Robinson A. Best Practice Guidelines on Publication Ethics: a Publisher’s Perspective. Int J Clin Pract 2007; 61(Suppl. 152): 1–26.
  2. Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 2005; 21: 317–321.

 

Fraudulent claims: In order to minimise the possibility of fraudulent research claims, the Editors reserve the right to request further information about any article submitted for publication to European Diabetes Nursing prior to or after publication.

 

Editor’s discretion: The Editor reserves the right to shorten or to make other alterations to articles accepted for publication at their discretion.

 

Reprints and copies of articles: Complimentary copies of the issue are sent to authors. Reprints of articles for authors can be obtained at cost from the publishers. Single copies of articles may be photocopied by clinicians without permission or payment.

 

For further information: contact Helen Tupsy, European Diabetes Nursing, John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester PO19 8SQ, UK Tel +44 (0)1243 770520. Fax +44 (0)1243 770144. Email: htupsy@wiley.com

SEARCH

SEARCH BY CITATION